Human KLF6 Antibody Summary
Met1-Ser109
Accession # Q99612
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: KLF6
KLF6 is a ubiquitously expressed nuclear protein belonging to the Kruppel C2H2-type zinc finger transcription factor family. It is a 283 amino acid (aa) protein that contains an N-terminal acidic domain, a Ser/Thr-rich region and three zinc-finger motifs. The acidic region may interact with other transcription factors. The Ser-Thr-rich region likely serves as an activation domain, and the zinc-finger motifs bind DNA. One alternate splice form is known that shows a 55 aa substitution for the C‑terminal 57 amino acids. KLF6 is considered a tumor-suppressor gene. It also promotes iNOS and TGF-beta 1 expression. Human KLF6 shares 94%, 95% and 94% aa sequence identity with rat, mouse and canine KLF6, respectively.
Product Datasheets
Citations for Human KLF6 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
4
Citations: Showing 1 - 4
Filter your results:
Filter by:
-
Tumor-Derived Extracellular Vesicles Promote Activation of Carcinoma-Associated Fibroblasts and Facilitate Invasion and Metastasis of Ovarian Cancer by Carrying miR-630
Authors: Yulan Cui, Deying Wang, Min Xie
Frontiers in Cell and Developmental Biology
-
Apremilast ameliorates ox-LDL-induced endothelial dysfunction mediated by KLF6
Authors: Hao Wang, Guang Yang, Qian Zhang, Xiao Liang, Yang Liu, Meng Gao et al.
Aging (Albany NY)
-
Upregulating CD59: a new strategy for protection of neurons from complement-mediated degeneration
Authors: M V Kolev, T Tediose, B Sivasankar, C L Harris, J Thome, B P Morgan et al.
The Pharmacogenomics Journal
-
Modulation of CD59 expression by restrictive silencer factor-derived peptides in cancer immunotherapy for neuroblastoma.
Authors: Donev RM, Gray LC, Sivasankar B, Hughes TR, van den Berg CW, Morgan BP
Cancer Res., 2008-07-15;68(14):5979-87.
Species: Human
Sample Types: Cell Lysates
Applications: Immunoprecipitation
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human KLF6 Antibody
There are currently no reviews for this product. Be the first to review Human KLF6 Antibody and earn rewards!
Have you used Human KLF6 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image